Skip to main content

Table 3 post-operative measures

From: Safety and efficacy of Holmium laser enucleation of the prostate (HoLEP) in patients with previous transperineal biopsy (TPB): outcomes from a dual-centre case-control study

  Group 1 Group 2 Difference (95% CI) p value
Qmax (mL/sec) 17.3 (±6.7) 22.2 (±15.1) 5.1 (− 4.1, 14.1) 0.264
PVR (mL) 70.9 (±121.6) 63.1 (±84.4) 7.8 (−76.1, 91.7) 0.847
IPSS 6.2 (±4.5) 6.2 (±5.8) 0.1 (−2.9, 2.9) 0.990
Quality of life score 1.0 (±0.8) 1.5 (±1.74) 0.5 (−0.1, 1.1) 0.116
Mean hospital stay (days) 1.3 (1.0) 3.0 (3.6) 1.7 (0.45, 0.77) < 0.001
  1. CI Confidence intervals, Qmax maximum flow rate, PVR Post-void residual volume, IPSS International Prostate Symptom Score. Data presented as mean (SD).